Constellation Brands heads into late April having given back most of its post-earnings pop, with analysts raising targets but the stock sliding back toward the Street's most cautious price points.
The tension here is straightforward. STZ jumped roughly 10.6% the day after its Q4 results on April 9, and held those gains for several days — a clean positive reaction by any measure. But the stock has since retreated 4.1% over the past week and 3.2% in yesterday's session alone, closing at $150.40. That puts it trading fractionally above B of A's $154 target and below Deutsche Bank's $155 — and well below the mean Street target of $177.55. The post-earnings relief rally has stalled, and the stock now sits where the bears feel vindicated.
Short interest is not the central concern here, but it is worth noting the recent move in positioning. SI had been falling steadily through April — down 13.4% over the month — reaching a low around 5.84 million shares. It ticked back up 8.7% on April 28 to 6.37 million shares, or 3.7% of the free float. That one-day jump is worth watching, though at roughly 2 days-to-cover and borrow running at just 0.41%, the lending market is loose. The ORTEX short score edged up to 39.1 on April 28 — a two-week high — but that move is modest and availability remains ample. Shorts are not squeezed; if anything, the uptick after the stock's pullback suggests some incremental positioning against the recovery thesis. Options are similarly relaxed: the put/call ratio was 0.85, below its 20-day average of 0.87, placing it slightly toward the call-heavy end of its recent range. There is no unusual defensive hedging in the options market.
The analyst story is where the real debate sits. The April 9 results triggered a broad wave of target-price increases. TD Cowen stood out, upgrading from Hold to Buy and lifting its target from $142 to $190. The more cautious shops also moved — Barclays raised from $151 to $170, Morgan Stanley from $160 to $183, UBS from $176 to $186, Wells Fargo from $180 to $185. The direction of travel is clearly higher: most of the Street lifted numbers after seeing the print, with consensus at 11 buys and 8 holds. Yet the persistence of that BofA Underperform at $154 and Deutsche Bank's Hold at $155 frames the floor — and the stock is now trading right against it. The bull case rests on Corona and Modelo continuing to take beer market share, on the Hispanic consumer stabilising, and on a portfolio that has limited international revenue risk. The bear case is that those same consumer headwinds — weaker Hispanic consumer sentiment, macro pressure on the mid-market drinker — remain live, EPS forward momentum ranks in just the 12th percentile for year-on-year growth, and the 30-day PE re-rating has been positive (up 0.85 to 12.9x) even as the price has slipped, implying earnings estimates have also come down.
On institutional ownership, the structure is stable but not unanimous. Berkshire Hathaway holds 13 million shares (7.6% of the company) as of December 2025, trimmed slightly from a prior position. Capital Research added significantly in Q1 2026 — a 2.4 million share increase — while Vanguard also added roughly 786,000 shares. The Sands family-related holdings through RSS Business Holdings and RES Business Holdings collectively account for another 6.5% of shares outstanding and have been unchanged. That concentrated founder-and-institutional base provides ballast, but the recent director sell — board member Ernesto Hernandez disposing of 2,000 shares at $153.92 on April 27 — is a small but timely reminder that insiders are using the bounce to lighten up, not add. The 90-day net insider position is marginally net positive in share terms, but entirely explained by routine awards rather than open-market purchases.
The next earnings call is scheduled for June 26. With the stock trading almost $27 below the analyst mean target and right on top of the most bearish Street levels, the June print will resolve whether the Q4 beat was a turning point or a one-quarter reprieve — and the recent short interest uptick suggests at least some market participants are leaning toward the latter.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
